Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer. [Phase 1, Phase 2]
The document summarizes a Phase 1/Phase 2 clinical trial evaluating ASKB589 in combination with CAPOX chemotherapy and PD-1 inhibitors for p…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: COMBO Endoscopy Oropharyngeal Airway Reduces Hypoxia During Sedated Gastrointestinal Endoscopy in Obese Patients: A Multicenter, Randomized, Controlled Clinical Trial [NA]
A multicenter randomized clinical trial evaluating whether the COMBO Endoscopy Oropharyngeal Airway reduces hypoxia during sedated gastroint…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) [Phase 2]
Phase 2 randomized trial evaluating neoadjuvant radiotherapy plus tegafur, oxaliplatin, iparomlimab, and tuvonralimab in resectable gastric …
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer [EARLY_Phase 1]
This document outlines an early Phase 1 clinical trial evaluating NK510 for safety and efficacy in gastric cancer and colorectal cancer, wit…
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is assessing SHR2554 in combination with other antitumor therapies for advanced/metastatic gastric cancer and gastr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-10Clinical Trial Update: The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma [NA]
Clinical trial update for a second-line combination of Iparomlimab and Tuvonralimab with albumin-bound paclitaxel in advanced gastric or gas…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors [Phase 1]
This clinical trial update describes a first-in-human Phase 1 study of an investigational therapy in adults with advanced solid tumors, incl…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating sorbitol with neoadjuvant chemotherapy plus Tirellizumab (PD-1 inhib…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: A Study of NX-1607 in Adults With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating NX-1607 in adults with advanced malignancies is actively recruiting across multiple tumor types, including ovaria…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating Glumetinib in combination with Nab-docetaxel for advanced gastric/gastroesophageal junction cancers and ot…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive Gastrectomy [NA]
A clinical trial is evaluating whether enhanced recovery after surgery (ERAS) improves postoperative recovery after minimally invasive gastr…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer [NA]
A clinical trial sponsored by Amsterdam UMC compares omentum preservation versus complete omentectomy during gastrectomy for gastric cancer …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Immunotherapy Combined With Anti-angiogenic Therapy and Chemotherapy for Potentially Resectable MSI-H, dMMR Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
A Phase 2 clinical trial is evaluating a combination of immunotherapy, anti-angiogenic therapy, and chemotherapy in MSI-H/dMMR locally advan…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors [Phase 1]
Phase 1 trial of SON-DP in participants with relapsed/refractory solid tumors intolerant to standard therapies, including gastric cancer and…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Exploration of Lymph Node Metastasis and Tumor Deposit in the Posterior Gastric Mesentery for Distal Gastric Cancer
A clinical trial is recruiting to study lymph node metastasis and tumor deposits in the posterior gastric mesentery for distal gastric cance…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer
A clinical trial update (NCT06728878) examining lymph node metastasis and tumor deposits in the short gastric mesentery after total gastrect…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy
This clinical trial update describes a study evaluating tumor deposits at the fusion site of the right gastric mesentery and left gastric me…
-
CLINICAL_TRIALS research · 2025-08-29Clinical Trial Update: Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation
A prospective study evaluating sentinel lymph node detection in gastric cancer using dual tracers (superparamagnetic iron oxide and methylen…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma
Clinical trial update describing a matching-adjusted indirect comparison (MAIC) of Fruquintinib plus paclitaxel versus ramucirumab plus pacl…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Cytoreductive Gastrectomy After Systemic Therapy Versus Systemic Therapy Alone For Limited Metastasis Gastric Cancer [NA]
This clinical trial evaluates cytoreductive gastrectomy after systemic therapy versus systemic therapy alone for limited metastatic gastric …
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: [18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric Cancer [Phase 2, Phase 3]
This Phase 2/Phase 3 trial from Leiden University Medical Center is evaluating [18F]F-FAPI PET/CT with laparoscopy for staging locally advan…
-
CLINICAL_TRIALS research · 2025-08-26Clinical Trial Update: Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical Trial [NA]
An ongoing randomized controlled trial compares safety outcomes of total laparoscopic proximal gastrectomy with and without preserving the c…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: HER-2 B Cell Peptide Vaccine [Phase 1]
Phase 1 clinical trial update for a HER-2 B cell peptide vaccine in metastatic breast and gastric cancers; recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 multicenter trial evaluating IBI343 monotherapy versus investigator's choice in previously treated CLDN18.2-positive, HER2-negative …
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Guardant Health's ORACLE trial is currently recruiting to evaluate residual cancer using a liquid biopsy across multiple cancer types.